DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
South Korea
· Delayed Price · Currency is KRW 5,260.00
+270.00 (5.41%)
Last updated: Mar 25, 2025
DongKoo Bio & Pharma Revenue
In the year 2024, DongKoo Bio & Pharma had annual revenue of 249.27B KRW with 15.57% growth. DongKoo Bio & Pharma had revenue of 57.57B in the quarter ending December 31, 2024, a decrease of -7.15%.
Revenue
249.27B
Revenue Growth
+15.57%
P/S Ratio
0.56
Revenue / Employee
654.26M
Employees
381
Market Cap
139.54B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |